The gamma-glutamyl transpeptidase to platelet ratio (GPR) shows poor correlation with transient elastography measurements of liver fibrosis in HIV-positive patients with chronic hepatitis B in West Africa. Response to: 'The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant l

@article{Stockdale2016TheGT,
  title={The gamma-glutamyl transpeptidase to platelet ratio (GPR) shows poor correlation with transient elastography measurements of liver fibrosis in HIV-positive patients with chronic hepatitis B in West Africa. Response to: 'The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant l},
  author={Alexander J Stockdale and Richard Odame Phillips and Anna Mar{\'i}a Geretti},
  journal={Gut},
  year={2016},
  volume={65 5},
  pages={882-4}
}
Lemoine et al’s excellent article from the Gambia reported on non-invasive markers of liver fibrosis in patients with chronic HBV infection. They propose a novel biomarker—the gamma-glutamyl transpeptidase (GGT) to platelet ratio (GPR)— as a routinely available test that could identify patients with fibrosis or cirrhosis in resource-limited settings, thereby informing prognosis and guiding monitoring. Notably, the study excluded patients with conditions that might predispose to altered GGT or… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 3 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-6 of 6 extracted citations

Liver fibrosis in treatment-naïve HIV-infected and HIV/HBV co-infected patients: Zambia and Switzerland compared.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases • 2016

Similar Papers

Loading similar papers…